Margarida Maia, PhD,  science writer—

Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.

Articles by Margarida Maia

Phase 1/2a trial of NK cell therapy SNK01 wins FDA clearance

NKGen Biotech plans to begin clinical testing of SNK01, a natural killer (NK) cell therapy being developed to treat neurodegenerative diseases, in people with Parkinson’s disease, the company announced. This follows a go-ahead by the U.S. Food and Drug Administration (FDA) for an investigational new drug (IND) application…

Pilates may ease Parkinson’s disease upper limb bradykinesia

A six-week Pilates-based exercise program helped reduce bradykinesia of the upper limbs in a small group of people with Parkinson’s disease, a study from Brazil reports. The study, “Short-term effects of Pilates-based exercise on upper limb strength and function in people with Parkinson’s disease,” was published in the…

Sleep, digestive issues linked to Parkinson’s psychosis: Study

People with Parkinson’s disease who experience digestive issues or probable rapid eye movement (REM) sleep behavior disorder may be as much as twice as likely to develop symptoms of psychosis, a study found. Understanding what predicts early-onset psychosis in Parkinson’s can help doctors identify at-risk patients sooner, enabling them…